| 55.38 Data as of May 21 |  +0.30 / +0.54%Today’s Change | 37.26 Today|||52-Week Range 55.71 | +22.20% Year-to-Date |
| Previous close | 55.08 |
| Today’s open | 54.95 |
| Day’s range | 54.79 - 55.71 |
| Volume | 50,282 |
| Average volume (3 months) | 75,591 |
| Market cap | $1.3B |
| Dividend yield | -- |
| Earnings growth (last year) | -2.08% |
| Earnings growth (this year) | +20.01% |
| Earnings growth (next 5 years) | +17.00% |
| Revenue growth (last year) | +6.58% |
| P/E ratio | 51.3 |
| Price/Sales | 4.96 |
| Price/Book | 5.94 |
| Today’s change | Today’s % change | |
|---|---|---|
| GHDXGenomic Health Inc | +0.03 | +0.08% |
| VIVOMeridian Bioscience ... | +0.08 | +0.37% |
| QDELQuidel Corp | -0.20 | -0.88% |
| DNDNDendreon Corp | +0.02 | +0.51% |
| Next reporting date | July 23, 2013 |
| EPS forecast (this quarter) | $0.30 |
| Annual revenue (last year) | $184.0M |
| Annual profit (last year) | $22.5M |
| Net profit margin | 12.23% |
Sector Health Technology |
Industry Medical Specialties |
Chairman & Chief Executive Officer James L. Herbert |
President, Chief Operating Officer & Director Lon M. Bohannon, CPA |
Corporate headquarters Lansing, Michigan |
.
